Search

everythinglearnresearchcommunity

for

Search:↓

Visible lesions are not always needed to diagnose tinea capitis.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

Dermatologists should learn trichoscopy to better diagnose hair loss conditions.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.

A 5-year-old boy was diagnosed with congenital triangular alopecia, a type of hair loss without skin changes, usually starting between ages 2-5, with no specific treatment.

A man experienced hair loss from radiotherapy, which can be temporary or permanent depending on radiation dose, with potential treatments available.

Congenital triangular alopecia is a hair loss condition present from birth or early childhood with no effective treatment needed.

Triangular temporal alopecia can occur in adults and should be correctly identified to prevent misdiagnosis.

Scalp allergic reactions are often missed, needing specific tests and avoiding certain hair products for proper treatment.

Hair transplant combining scalp and beard hair with PRP was successful for scarring alopecia.

The SAALIQ is a reliable tool for measuring the impact of alopecia areata on Spanish-speaking patients' quality of life.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Alopecia areata is increasing globally, with disparities needing better prevention and support.

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

COVID-19 vaccination may be linked to alopecia areata, especially in young adults.

Unani medicine helped regrow eyebrow hair in 45 days.

People with alopecia areata had lower vitamin D levels, but these levels didn't relate to many aspects of the condition.

People with alopecia areata often have lower vitamin D levels than healthy people.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Early recognition and treatment of atypical alopecia areata in infants are crucial.